Search research articles
Contact Us
Filters
Showing results (41-50 of 265) with videos related to
Page
of 27
Sort By:
Annals of Surgical Oncology
|
August 3, 2017
Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology
|
July 14, 2021
Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy
Jennifer E Tonneson, Tanya L Hoskin, Diane M Durgan, et al.
Journal of the National Cancer Institute
|
April 5, 2014
Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA
Matthew P Goetz, Hiltrud Brauch, Mark J Ratain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2025
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer"
Matthew P Goetz, Grace M Choong, Tanya L Hoskin, et al.
NPJ Breast Cancer
|
October 26, 2017
Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study
Prema P Peethambaram, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology
|
August 3, 2017
Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study
Toan T Nguyen, Tanya L Hoskin, Courtney N Day, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
December 4, 2014
Pregnancy-associated plasma protein-A expression in human breast cancer
Aaron S Mansfield, Daniel W Visscher, Steven N Hart, et al.
Breast Cancer Research : BCR
|
March 14, 2012
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo
Ashwani Khurana, Hiedi McKean, Hyunseok Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to A.-S. Dieudonné et al and J.M. Rae et al
Hiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters
Hiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Page
of 27
Search research articles
Search
Showing results (41-50 of 265) with videos related to
Sort By:
Page
of 27
Annals of Surgical Oncology
|
August 3, 2017
Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology
|
July 14, 2021
Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy
Jennifer E Tonneson, Tanya L Hoskin, Diane M Durgan, et al.
Journal of the National Cancer Institute
|
April 5, 2014
Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA
Matthew P Goetz, Hiltrud Brauch, Mark J Ratain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 28, 2025
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer"
Matthew P Goetz, Grace M Choong, Tanya L Hoskin, et al.
NPJ Breast Cancer
|
October 26, 2017
Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study
Prema P Peethambaram, Tanya L Hoskin, Courtney N Day, et al.
Annals of Surgical Oncology
|
August 3, 2017
Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study
Toan T Nguyen, Tanya L Hoskin, Courtney N Day, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
December 4, 2014
Pregnancy-associated plasma protein-A expression in human breast cancer
Aaron S Mansfield, Daniel W Visscher, Steven N Hart, et al.
Breast Cancer Research : BCR
|
March 14, 2012
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo
Ashwani Khurana, Hiedi McKean, Hyunseok Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 2013
Reply to A.-S. Dieudonné et al and J.M. Rae et al
Hiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2012
Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters
Hiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Page
of 27